Published in Cancer Weekly, January 11th, 2005
The discovery, which appears in the peer-reviewed journal Clinical Cancer Research, may allow oncologists to customize "targeted" cancer treatments for each patient based on the molecular make-up of their tumors. These "smart drugs" selectively stop the growth of tumor cells with the molecular abnormality. This is in striking contrast to chemotherapy drugs, which are not administered on the basis of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.